Showing results (191-200 of 465) with videos related to

Sort By:
Pageof 47
Urologia Internationalis|November 2, 2018
Strong Expression of Cancertestis Antigens CTAG1B and MAGEA3 Is Correlated with Unfavourable Histopathological Features and MAGEA3 Is Associated with Worse Progression-Free Survival in Urothelial Bladder CancerEva Maria Lausenmeyer, Klara Braun, Johannes Breyer, et al.
Urology|October 13, 2009
Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumorsMaximilian Burger, Christian G Stief, Dirk Zaak, et al.
BJU International|August 17, 2010
The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancerWolfgang Otto, Stefan Denzinger, Hans-Martin Fritsche, et al.
European Urology|September 20, 2011
Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a multicentre studyEugene K Cha, Lenuta-Ancuta Tirsar, Christian Schwentner, et al.
World Journal of Urology|November 6, 2012
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancerEugene K Cha, Lenuta-Ancuta Tirsar, Christian Schwentner, et al.
Urologia Internationalis|July 4, 2015
Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter StudyThomas Martini, Atiqullah Aziz, Florian Roghmann, et al.
European Urology|May 29, 2012
Combination of CK20 and Ki-67 immunostaining analysis predicts recurrence, progression, and cancer-specific survival in pT1 urothelial bladder cancerSimone Bertz, Wolfgang Otto, Stefan Denzinger, et al.
Urologia Internationalis|December 23, 2024
Does Time Matter in Early Radical Cystectomy? Comparing Outcome, Clinical, and Pathological Characteristics of Immediate versus Deferred Radical CystectomyYushan Yang, Sonja Holbach, Maximilian Haas, et al.
Pathology Oncology Research : POR|September 12, 2019
Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC)Philipp J Spachmann, Vanessa Azzolina, Florian Weber, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 1, 2019
Sedentary Behavior and Prostate Cancer: A Systematic Review and Meta-Analysis of Prospective Cohort StudiesFelix F Berger, Michael F Leitzmann, Andrea Hillreiner, et al.
Pageof 47